Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
EBITDA (including other income) stood at Rs 636.9 crore, up 12.1% compared with Rs 568 crore recorded in Q4 FY25. Margin improved 90 bps to 21% in Q4 FY26 as against 20.1% in Q4 FY25.
The India FMCG Business posted a growth of 9.5% during the quarter while operating profit from the segment rose 12.5% during the quarter, supported by strong execution in the domestic FMCG business and underlying volume growth of 6%.
The company’s hair care portfolio grew by about 27% during the quarter, led by the hair oils business which reported a 28% growth. The home care business posted an over 24% growth, while the digestives business expanded around 15% in Q4 FY26.
The skin & salon business grew by over 12% while the toothpaste category rose over 7%. The OTC & ethicals business also registered around 7% growth. The Badshah portfolio recorded 12% growth during the quarter.
Mohit Malhotra, global chief executive officer, Dabur India, said: “despite inflationary pressures, Dabur leveraged its strong brand superiority to deliver healthy growth across the key and highly competitive home & personal care and healthcare categories. The company's business fundamentals remain robust, with brands across honey, health juices, digestives, oral care, hair care, healthcare, air fresheners, and foods reporting strong gains during the quarter.
On international front, the company’s international business grew by 2.5% during the quarter despite facing headwinds in Middle East. Growth was driven by Sub-Saharan Africa (20%), UK & EU (10%); Namaste US (6.2%) and Bangladesh (22%).
On an annual basis, the company’s consolidated net profit rose 7.21% to Rs 1,895.03 crore on 5.01% rise in revenue from operations to Rs 13,192.57 crore in FY26 over FY25.
Mohit Malhotra, said, “In the fourth quarter, rural markets continued to outpace urban consumption with rural demand growing ahead of urban India by 350bps. That said, the gap between rural and urban growth has narrowed significantly compared to December 2025, reflecting a more balanced consumption recovery.
We expect this convergence to continue. Within Urban India, e-commerce and Modern Trade have been driving demand, growing by 49% and 19% respectively. Quick Commerce is driving the online business, posting a growth of 54%. This channel was a major contributor to our foods business, which grew by 30% in Q4. We will continue to double down on emerging channels, which serve as the incubators for Dabur's innovation and premium products. As part of this initiative, we have launched SIENS, Dabur's first online only Direct-to-Consumer nutraceutical brand, which is showing great consumer traction. We continue to invest heavily behind this brand,”
Meanwhile, the company’s board recommended a final dividend of Rs 5.50 per equity share having face value of Re 1 each for the financial year 2025-26. The record date has been fixed as July 17 2026.
Dabur India is one of India's leading FMCG companies. The company manufactures personal care, healthcare and food products. Its portfolio includes eight major power brands- Dabur Chyawanprash, Dabur Honey, Honitus, PudinHara and Dabur Lal Tail in the healthcare catrogory, Dabur Amla and Dabur Red Paste in the personal care and Real in the food & beverages space.
Dabur India Ltd rose for a fifth straight session today. The stock is quoting at Rs 487.55, up 3.73% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.67% on the day, quoting at 24164.3. The Sensex is at 77254.26, down 0.76%. Dabur India Ltd has added around 13.54% in last one month.
Meanwhile, Nifty FMCG index of which Dabur India Ltd is a constituent, has added around 7.42% in last one month and is currently quoting at 51068.45, up 0.21% on the day. The volume in the stock stood at 97.11 lakh shares today, compared to the daily average of 21.63 lakh shares in last one month.
The benchmark May futures contract for the stock is quoting at Rs 489.5, up 3.92% on the day. Dabur India Ltd is up 5.36% in last one year as compared to a 0.65% gain in NIFTY and a 8.01% gain in the Nifty FMCG index.
The PE of the stock is 57.18 based on TTM earnings ending December 25.
For the full year,net profit rose 7.21% to Rs 1895.03 crore in the year ended March 2026 as against Rs 1767.63 crore during the previous year ended March 2025. Sales rose 5.01% to Rs 13192.57 crore in the year ended March 2026 as against Rs 12563.09 crore during the previous year ended March 2025.
The counter rose 0.79% to settle at Rs 470.05 on the BSE.
Dabur India Ltd, Grasim Industries Ltd, Emami Ltd, Authum Investment & Infrastructure Ltd are among the other stocks to see a surge in volumes on BSE today, 10 March 2026.
Coromandel International Ltd clocked volume of 11.27 lakh shares by 10:53 IST on BSE, a 35.14 times surge over two-week average daily volume of 32076 shares. The stock gained 0.98% to Rs.2,018.70. Volumes stood at 12226 shares in the last session.
Dabur India Ltd witnessed volume of 10.16 lakh shares by 10:53 IST on BSE, a 26.45 times surge over two-week average daily volume of 38414 shares. The stock increased 2.18% to Rs.476.80. Volumes stood at 47889 shares in the last session.
Grasim Industries Ltd notched up volume of 5.16 lakh shares by 10:53 IST on BSE, a 7.47 fold spurt over two-week average daily volume of 69135 shares. The stock rose 1.49% to Rs.2,720.00. Volumes stood at 4.32 lakh shares in the last session.
Emami Ltd registered volume of 1.25 lakh shares by 10:53 IST on BSE, a 5.07 fold spurt over two-week average daily volume of 24629 shares. The stock rose 0.07% to Rs.443.40. Volumes stood at 72611 shares in the last session.
Authum Investment & Infrastructure Ltd witnessed volume of 82919 shares by 10:53 IST on BSE, a 4.44 times surge over two-week average daily volume of 18669 shares. The stock increased 15.53% to Rs.466.50. Volumes stood at 37736 shares in the last session.
Dabur India Ltd, Grasim Industries Ltd, Emami Ltd, Pfizer Ltd are among the other stocks to see a surge in volumes on BSE today, 10 March 2026.
Coromandel International Ltd recorded volume of 11.26 lakh shares by 10:45 IST on BSE, a 35.1 times surge over two-week average daily volume of 32076 shares. The stock gained 0.61% to Rs.2,011.25. Volumes stood at 12226 shares in the last session.
Dabur India Ltd clocked volume of 10.12 lakh shares by 10:45 IST on BSE, a 26.35 times surge over two-week average daily volume of 38414 shares. The stock gained 2.09% to Rs.476.40. Volumes stood at 47889 shares in the last session.
Grasim Industries Ltd clocked volume of 5.15 lakh shares by 10:45 IST on BSE, a 7.45 times surge over two-week average daily volume of 69135 shares. The stock gained 1.65% to Rs.2,724.20. Volumes stood at 4.32 lakh shares in the last session.
Emami Ltd notched up volume of 1.25 lakh shares by 10:45 IST on BSE, a 5.06 fold spurt over two-week average daily volume of 24629 shares. The stock slipped 0.25% to Rs.442.00. Volumes stood at 72611 shares in the last session.
Pfizer Ltd registered volume of 3302 shares by 10:45 IST on BSE, a 3.69 fold spurt over two-week average daily volume of 894 shares. The stock rose 0.25% to Rs.4,784.65. Volumes stood at 1050 shares in the last session.
RAS Beauty is the first investment from Dabur Ventures, which was launched in October 2025 with an intent to acquire stake in high-potential, new-age D2C businesses that demonstrate strong growth potential and are closely aligned with Dabur’s long-term strategic vision. Dabur plans to invest around Rs 60 crore in RAS Beauty.
Dabur India executive director – group head corporate strategy, Mr. Abhinav Dhall, said: “We are very impressed with the passion and commitment with which Shubhika Jain and her family have built RAS Beauty always keeping the consumer at the forefront. RAS offers a distinct skincare value proposition at the confluence of nature, science and luxury. We believe that the premium beauty segment will witness strong growth in the coming decade and RAS Beauty is well positioned to capture the emerging opportunity.”
RAS Beauty co-founder and CEO Ms Shubhika Jain said: 'We have been inspired by Dabur's 141-year legacy of building purpose-led, trusted consumer brands. Dabur has proved that nature, science, and consumer trust can coexist at scale, and that is exactly what we are building at RAS. This investment will enable us to accelerate our omnichannel presence, deepen our R&D capabilities, and invest in brand and team building, all in pursuit of our longer-term goal of making RAS a leading name in Indian luxury skincare, at home and globally, while staying true to our core values.”
Dabur is one of India’s leading FMCG companies, specializing in Ayurveda and natural health care, with an extensive distribution network spanning India and key international markets.
The company reported a 7.3% increase in consolidated net profit to Rs 553.61 crore on a 6.1% rise in revenue from operations to Rs 3,558.65 crore in Q3 FY26 over Q3 FY25.
The counter fell 2.55% to Rs 494.65 on the BSE.